TAZ is required for metastatic activity and chemoresistance of breast cancer stem cells (original) (raw)

• Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM . Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893–2917.
  Article CAS Google Scholar
• Saini V, Shoemaker RH . Potential for therapeutic targeting of tumor stem cells. Cancer Sci 2010; 101: 16–21.
  Article CAS Google Scholar
• Kakarala M, Wicha MS . Implications of the cancer stem-cell hypothesis for breast cancer prevention and therapy. J Clin Oncol 2008; 26: 2813–2820.
  Article Google Scholar
• Maugeri-Sacca M, Vigneri P, De Maria R . Cancer stem cells and chemosensitivity. Clin Cancer Res 2011; 17: 4942–4947.
  Article CAS Google Scholar
• Zhou BB, Zhang H, Damelin M, Geles KG, Grindley JC, Dirks PB . Tumour-initiating cells: challenges and opportunities for anticancer drug discovery. Nat Rev Drug Discov 2009; 8: 806–823.
  Article CAS Google Scholar
• Schatton T, Murphy GF, Frank NY, Yamaura K, Waaga-Gasser AM, Gasser M et al. Identification of cells initiating human melanomas. Nature 2008; 451: 345–349.
  Article CAS Google Scholar
• Malanchi I, Santamaria-Martinez A, Susanto E, Peng H, Lehr HA, Delaloye JF et al. Interactions between cancer stem cells and their niche govern metastatic colonization. Nature 2012; 481: 85–89.
  Article CAS Google Scholar
• Baccelli I, Schneeweiss A, Riethdorf S, Stenzinger A, Schillert A, Vogel V et al. Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay. Nat Biotechnol 2013; 31: 539–544.
  Article CAS Google Scholar
• Harvey KF, Zhang X, Thomas DM . The Hippo pathway and human cancer. Nat Rev Cancer 2013; 13: 246–257.
  Article CAS Google Scholar
• Cordenonsi M, Zanconato F, Azzolin L, Forcato M, Rosato A, Frasson C et al. The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells. Cell 2011; 147: 759–772.
  Article CAS Google Scholar
• Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008; 133: 704–715.
  Article CAS Google Scholar
• Perrone G, Gaeta LM, Zagami M, Nasorri F, Coppola R, Borzomati D et al. In situ identification of CD44+/CD24- cancer cells in primary human breast carcinomas. PLoS One 2012; 7: e43110.
  Article CAS Google Scholar
• Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C et al. Identification and expansion of human colon-cancer-initiating cells. Nature 2007; 445: 111–115.
  Article CAS Google Scholar
• Eramo A, Lotti F, Sette G, Pilozzi E, Biffoni M, Di Virgilio A et al. Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ 2008; 15: 504–514.
  Article CAS Google Scholar
• Ponti D, Costa A, Zaffaroni N, Pratesi G, Petrangolini G, Coradini D et al. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res 2005; 65: 5506–5511.
  Article CAS Google Scholar
• Grefte S, Vullinghs S, Kuijpers-Jagtman AM, Torensma R, Von den Hoff JW . Matrigel but not collagen I, maintains the differentiation capacity of muscle derived cells in vitro. Biomed Mater 2012; 7: 055004.
  Article CAS Google Scholar
• Dontu G, Abdallah WM, Foley JM, Jackson KW, Clarke MF, Kawamura MJ et al. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev 2003; 17: 1253–1270.
  Article CAS Google Scholar
• Zhao B, Lei QY, Guan KL . The Hippo-YAP pathway: new connections between regulation of organ size and cancer. Curr Opin Cell Biol 2008; 20: 638–646.
  Article CAS Google Scholar
• Lladser A, Sanhueza C, Kiessling R, Quest AF . Is survivin the potential Achilles' heel of cancer? Adv Cancer Res 2011; 111: 1–37.
  Article CAS Google Scholar
• Yin D, Chen W, O'Kelly J, Lu D, Ham M, Doan NB et al. Connective tissue growth factor associated with oncogenic activities and drug resistance in glioblastoma multiforme. Int J Cancer 2010; 127: 2257–2267.
  Article CAS Google Scholar
• Chaffer CL, Weinberg RA . A perspective on cancer cell metastasis. Science 2011; 331: 1559–1564.
  Article CAS Google Scholar
• Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN . Overview of resistance to systemic therapy in patients with breast cancer. Adv Exp Med Biol 2007; 608: 1–22.
  Article CAS Google Scholar
• Morris PG, McArthur HL, Hudis CA . Therapeutic options for metastatic breast cancer. Expert Opin Pharmacother 2009; 10: 967–981.
  Article CAS Google Scholar
• Lai D, Ho KC, Hao Y, Yang X . Taxol resistance in breast cancer cells is mediated by the hippo pathway component TAZ and its downstream transcriptional targets Cyr61 and CTGF. Cancer Res 2011; 71: 2728–2738.
  Article CAS Google Scholar
• Abraham BK, Fritz P, McClellan M, Hauptvogel P, Athelogou M, Brauch H . Prevalence of CD44+/CD24-/low cells in breast cancer may not be associated with clinical outcome but may favor distant metastasis. Clin Cancer Res 2005; 11: 1154–1159.
  CAS Google Scholar
• Aktas B, Tewes M, Fehm T, Hauch S, Kimmig R, Kasimir-Bauer S . Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients. Breast Cancer Res 2009; 11: R46.
  Article Google Scholar
• Theodoropoulos PA, Polioudaki H, Agelaki S, Kallergi G, Saridaki Z, Mavroudis D et al. Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer. Cancer Lett 2010; 288: 99–106.
  Article CAS Google Scholar
• Balic M, Lin H, Young L, Hawes D, Giuliano A, McNamara G et al. Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype. Clin Cancer Res 2006; 12: 5615–5621.
  Article CAS Google Scholar
• Liu R, Wang X, Chen GY, Dalerba P, Gurney A, Hoey T et al. The prognostic role of a gene signature from tumorigenic breast-cancer cells. New Engl J Med 2007; 356: 217–226.
  Article CAS Google Scholar
• D'Amico L, Patane S, Grange C, Bussolati B, Isella C, Fontani L et al. Primary breast cancer stem-like cells metastasise to bone, switch phenotype and acquire a bone tropism signature. Br J Cancer 2013; 108: 2525–2536.
  Article CAS Google Scholar
• Cardoso F, Van't Veer L, Rutgers E, Loi S, Mook S, Piccart-Gebhart MJ . Clinical application of the 70-gene profile: the MINDACT trial. J Clin Oncol 2008; 26: 729–735.
  Article Google Scholar
• Lei QY, Zhang H, Zhao B, Zha ZY, Bai F, Pei XH et al. TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway. Mol Cell Biol 2008; 28: 2426–2436.
  Article CAS Google Scholar
• Chan SW, Lim CJ, Guo K, Ng CP, Lee I, Hunziker W et al. A role for TAZ in migration, invasion, and tumorigenesis of breast cancer cells. Cancer Res 2008; 68: 2592–2598.
  Article CAS Google Scholar
• Bartucci M, Svensson S, Romania P, Dattilo R, Patrizii M, Signore M et al. Therapeutic targeting of Chk1 in NSCLC stem cells during chemotherapy. Cell Death Differ 2012; 19: 768–778.
  Article CAS Google Scholar
• Pagliuca A, Valvo C, Fabrizi E, di Martino S, Biffoni M, Runci D et al. Analysis of the combined action of miR-143 and miR-145 on oncogenic pathways in colorectal cancer cells reveals a coordinate program of gene repression. Oncogene 2012; 32: 4806–4813.
  Article Google Scholar
• Bonci D, Cittadini A, Latronico MV, Borello U, Aycock JK, Drusco A et al. 'Advanced' generation lentiviruses as efficient vectors for cardiomyocyte gene transduction in vitro and in vivo. Gene Ther 2003; 10: 630–636.
  Article CAS Google Scholar